Literature DB >> 12819248

Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?

Angela Yee-Moon Wang1, Jean Woo, Christopher Wai-Kei Lam, Mei Wang, Mandy Man-Mei Sea, Siu-Fai Lui, Philip Kam-Tao Li, John Sanderson.   

Abstract

C-reactive protein is the prototype marker of inflammation and has been shown to predict mortality in hemodialysis patients. However, it remains uncertain as to whether a single C-reactive protein level has similar prognostic significance in peritoneal dialysis patients. A single high-sensitivity C-reactive protein (hs-CRP) level was measured in 246 continuous ambulatory peritoneal dialysis patients without active infections at study baseline together with indices of dialysis adequacy, echocardiographic parameters (left ventricular mass index, left ventricular dimensions, and ejection fraction), nutrition markers (serum albumin, dietary intake, and subjective global assessment) and biochemical parameters (hemoglobin, lipids, calcium, and phosphate). The cohort was then followed-up prospectively for a median of 24 mo (range, 2 to 34 mo), and outcomes were studied in relation to these parameters. Fifty-nine patients died (36 from cardiovascular causes) during the follow-up period. The median hs-CRP level was 2.84 mg/L (range, 0.20 to 94.24 mg/L). Patients were stratified into tertiles according to baseline hs-CRP, namely those with hs-CRP < or = 1.26 mg/L, 1.27 to 5.54 mg/L, and > or = 5.55 mg/L. Those with higher hs-CRP were significantly older (P < 0.001), had greater body mass index (P < 0.001), higher prevalence of coronary artery disease (P = 0.003), and greater left ventricular mass index (P < 0.001). One-year overall mortality was 3.9% (lower) versus 8.8% (middle) versus 21.3% (upper tertile) (P < 0.0001). Cardiovascular death rate was 2.7% (lower) versus 5.2% (middle) versus 16.2% (upper tertile) (P < 0.0001). Multivariable Cox regression analysis showed that every 1 mg/L increase in hs-CRP was independently predictive of higher all-cause mortality (hazard ratio [HR], 1.02; 95% CI, 1.01 to 1.04; P = 0.002) and cardiovascular mortality (HR, 1.03; 95% CI, 1.01 to 1.05; P = 0.001) in peritoneal dialysis patients. Other significant predictors for all-cause mortality included age (HR, 1.07; 95% CI, 1.04 to 1.10), gender (HR, 0.49; 95% CI, 0.27 to 0.90), atherosclerotic vascular disease (HR, 2.65; 95% CI, 1.46 to 4.80), left ventricular mass index (HR, 1.01; 95% CI, 1.00 to 1.01) and residual GFR (HR, 0.53; 95% CI, 0.38 to 0.75). Age (HR, 1.06; 95% CI, 1.02 to 1.10), history of heart failure (HR, 3.31; 95% CI, 1.36 to 8.08), atherosclerotic vascular disease (HR, 3.20; 95% CI, 1.43 to 7.13), and residual GFR (HR, 0.57; 95% CI, 0.38 to 0.86) were also independently predictive of cardiovascular mortality. In conclusion, a single, random hs-CRP level has significant and independent prognostic value in PD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819248     DOI: 10.1097/01.asn.0000070071.57901.b3

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

1.  Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients.

Authors:  Olga Balafa; Nynke Halbesma; Dirk G Struijk; Friedo W Dekker; Raymond T Krediet
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

Review 2.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

Review 3.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

4.  A linear relationship between serum high-sensitive C-reactive protein and hemoglobin in hemodialysis patients.

Authors:  Behzad Heidari; Muhammad Reza Fazli; Muhammad Ali Ghazi Misaeid; Parham Heidari; Niloofar Hakimi; Abbas Ali Zeraati
Journal:  Clin Exp Nephrol       Date:  2014-11-08       Impact factor: 2.801

Review 5.  Cardiovascular risk in the peritoneal dialysis patient.

Authors:  Raymond T Krediet; Olga Balafa
Journal:  Nat Rev Nephrol       Date:  2010-06-22       Impact factor: 28.314

6.  Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients.

Authors:  Jongha Park; Rajnish Mehrotra; Connie M Rhee; Miklos Z Molnar; Lilia R Lukowsky; Sapna S Patel; Allen R Nissenson; Joel D Kopple; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2013-06-05       Impact factor: 5.992

7.  Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis.

Authors:  Angela Yee-Moon Wang; Mei Wang; Christopher Wai-Kei Lam; Iris Hiu-Shuen Chan; Siu-Fai Lui; John E Sanderson
Journal:  Clin J Am Soc Nephrol       Date:  2011-01-06       Impact factor: 8.237

8.  Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?

Authors:  Angela Yee-Moon Wang; Christopher Wai-Kei Lam; Mei Wang; Iris Hiu-Shuen Chan; Siu-Fai Lui; John E Sanderson
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

Review 9.  ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.

Authors:  Angela Yee Moon Wang; K Scott Brimble; Gillian Brunier; Stephen G Holt; Vivekanand Jha; David W Johnson; Shin-Wook Kang; Jeroen P Kooman; Mark Lambie; Chris McIntyre; Rajnish Mehrotra; Roberto Pecoits-Filho
Journal:  Perit Dial Int       Date:  2015 Jul-Aug       Impact factor: 1.756

Review 10.  The clinical significance of vascular calcification in young patients with end-stage renal disease.

Authors:  Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2004-03-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.